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EPHPP = Effective Public Health Practice Project, GP = General Practitioner, NHS = National 
Health Service, PHE = Public Health England, PRISMA = Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses, RCT = Randomised Control Trials, WHO = World 
Health Organization 
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Introduction: Vaccination in pregnancy is an effective method to protect against disease for the 22 
pregnant woman, foetus and new born infant. In England, it is recommended that pregnant women 23 
are vaccinated against pertussis and influenza. Improvement in the uptake of both pertussis and 24 
influenza vaccination among pregnant women is needed to prevent morbidity and mortality for both 25 
the pregnant women and unborn child.  26 
 27 
Aim: To identify effective strategies in increasing the uptake of vaccination in pregnancy in high-28 
income countries and to make recommendations for England. 29 
 30 
Methods: A systematic review of peer reviewed literature was conducted using a keyword search 31 
strategy applied across six databases (Medline, Embase, PsychInfo, PubMed, CINAHL and Web of 32 
Science). Articles were screened against an inclusion and exclusion criteria and papers included 33 
within the review were quality assessed. 34 
 35 
Results and conclusions: Twenty-two articles were included in the review. The majority of the papers 36 
included were conducted in the USA and looked at strategies to increase influenza vaccination in 37 
pregnancy. There is limited high quality evidence for strategies in high-income countries to increase 38 
coverage of pertussis and influenza vaccination in pregnancy. A number of strategies have been 39 
found to be effective; reminders about vaccination on antenatal healthcare records, midwives 40 
providing vaccination, and education and information provision for healthcare staff and patients. 41 
Future interventions to increase vaccination in pregnancy should be evaluated to ensure efficacy 42 
and to contribute to the evidence base. 43 
 44 
Key Words:  45 
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1. Introduction 55 
 56 
Vaccination in pregnancy protects the pregnant woman, foetus and new born infant from harmful 57 
diseases [1-4]. For high-income countries, World Health Organisation (WHO) [5] recommends 58 
pregnant women are vaccinated against influenza and pertussis. In England, influenza vaccination in 59 
pregnancy has been offered since 2010 [6]. In April 2012, a pertussis outbreak occurred in England 60 
with 9,300 confirmed cases of pertussis and the death of 14 infants under three months old [7]. This 61 
prompted the Department of Health (DH) to offer the pertussis vaccine to all pregnant women from 62 
October 2012 to protect babies who are too young to be immunised [8]. The pertussis vaccination in 63 
pregnancy has been found to be 90 per cent effective at protecting infants in the first months after 64 
birth [9], safe to mother and foetus [2, 10] and is recommended by WHO [11] to prevent premature 65 
infant mortality. The vaccination is offered from 16 to 32 weeks gestation [6], and is also available 66 
up until delivery but does not offer the same level of protection to the infant [6].  67 
 68 
Pregnant women and infants are more at risk of morbidity and mortality from influenza than the 69 
general population [3-5, 12, 13, 14]. Between 2009 and 2012 influenza caused one out of 11 70 
maternal deaths [14]. Influenza in pregnant women can also have an impact on the growth and 71 
development of the foetus [4] and delivery complications, such as low birth weight and premature 72 
birth [14]. Infants under six months old are more at risk of severe complications and mortality from 73 
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contracting the influenza virus [15]. Infants in England are unable to receive the flu vaccination until 74 
they are six months old and only if they are in a clinical risk group, or ages two to seventeen years 75 
old otherwise [6].  76 
 77 
1.1 Vaccination rates in England 78 
 79 
Pertussis vaccination coverage in pregnancy in England has recently been increasing. Latest figures 80 
from Public Health England (PHE) indicate that 73.8 per cent of women were vaccinated in 81 
pregnancy between January and March 2017 [15]. However, previous years saw a dip in vaccination 82 
rates during the summer months. PHE have hypothesised that this is due to an increase in pertussis 83 
vaccination during flu season when influenza vaccination is also being promoted. 84 
 85 
Despite improvements in pertussis vaccination uptake in pregnancy, there have been 18 infant 86 
deaths related to pertussis in England since the programme began in 2012 [16]. For 16 of these 87 
deaths, the mother had not been vaccinated against pertussis during her pregnancy and for the 88 
other two infant deaths, the vaccination was administered too close to delivery to effectively protect 89 
the new born child [16]. Vaccination uptake also differs across regions in England, with some areas 90 
reporting lower uptake than others.  91 
 92 
Influenza vaccination rates during pregnancy in England were 44.9 per cent in 2016/17 season [17]. 93 
While this has increased from 42.3 per cent in the previous year (2015/16) [17] it compares 94 
unfavourably to uptake of influenza vaccination in 65 year olds (70.5%, 2016/17) [17] and other 95 
countries in the UK (for example, Scotland 61.5%, 2016/17) [18].  96 
 97 
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Caution should be taken when interpreting these pregnancy vaccination rates as data collection can 98 
be difficult due to the complexities of recording pregnancy and non-pregnancy accurately and in a 99 
timely manner on electronic health records [16].  100 
 101 
1.2 Current research on determinants of vaccination uptake in pregnancy 102 
 103 
Only a small portion of existing published research on determinants of vaccination uptake relates to 104 
vaccination in pregnancy [19, 20]. Wilson et al [19] conducted a literature review, which specifically 105 
focused on vaccine hesitancy in pregnancy. This paper found that the main factors reported to 106 
contribute to vaccine hesitancy were [19]: 107 
 Concerns about the safety of vaccination in pregnancy 108 
 Low knowledge about vaccine efficacy, the diseases and availability of vaccine 109 
 A healthcare worker not recommending the vaccination 110 
 111 
It is important to understand the factors that influence the decision to receive a vaccination to 112 
support the development of strategies and interventions to increase coverage of vaccination in 113 
pregnancy. While Wilson et al’s [19] review provides insight into the reasons pregnant women may 114 
be hesitant to receive a vaccination, it does not analyse the strategies that could help to increase 115 
uptake. 116 
 117 
A systematic review has been published to look at strategies to increase influenza vaccination in 118 
pregnancy in 2016 [21]. While this review by Wong et al [21] identified a number of strategies to 119 
increase influenza vaccination in pregnancy, it did not include pertussis vaccination. Also, the review 120 
only included papers up to August 2014. In order to make recommendations to an English setting on 121 
strategies to improve vaccination uptake in pregnant women in England, pertussis vaccination must 122 
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also be reviewed, especially since pertussis has different recommendations around the timing of 123 
vaccination in pregnancy compared with the influenza vaccine [6].  124 
 125 
The reason for selecting England rather than the UK as a whole is due to the Health and Social Care 126 
Act (2012) [22], which resulted in commissioning arrangements for vaccination delivery differing 127 
across the UK. However, it is expected that the findings of this paper will translate to other high-128 
income countries. 129 
 130 
1.3 Aims and objectives 131 
 132 
The aim of this systematic review is to identify strategies that are effective in increasing the uptake 133 
of vaccination in pregnancy in high-income countries and to make recommendations for England.  134 
 135 
Objectives 136 
 To identify and describe interventions to increase uptake of vaccination in pregnancy in 137 
high-income countries  138 
 139 
 To explore the effectiveness of any identified interventions and/or strategies to increase 140 
uptake of vaccination in pregnancy 141 
 142 
 To make recommendations on strategies to increase vaccination uptake in pregnancy in 143 
England 144 
 145 
 146 
2. Methods 147 
 148 
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2.1 Systematic Review Search Strategy 149 
 150 
The search strategy was developed around vaccination type, pregnancy and keywords to identify 151 
strategies or interventions to increase vaccination uptake (table 1 for search terms). The search term 152 
‘maternal’ was excluded from the search strategy due to the large number of irrelevant papers this 153 
generated in preliminary literature searches (which focused more on child vaccinations rather than 154 
vaccinations in pregnancy). 155 
 156 
The following six databases were searched: Medline, Embase, PsychInfo, PubMed, CINAHL and Web 157 
of Science using the same search terms (table 1 and figure 1) for peer reviewed journal articles. The 158 
search was conducted on 4th August 2017. 159 
 160 
2.2 Study Selection 161 
 162 
The papers were screened according to the inclusion and exclusion criteria detailed in table 2. We 163 
did not exclude studies based on their design but included all types of studies (e.g. Randomised 164 
Control Trials (RCTs), observational). 165 
 166 
 167 
Papers that purely focused on pandemic flu vaccination were excluded since pandemic flu 168 
vaccination is only available during a pandemic outbreak and strategies to increase vaccination 169 
uptake differ to those to increase seasonal influenza vaccination uptake. 170 
 171 
Studies that used cocooning or postnatal vaccination of mothers and family members of the child 172 
were also excluded as this method is not recommended in England and the aim of this systematic 173 
review was to review strategies to increase vaccination in pregnancy, not postnatal vaccination. 174 
 8 
 175 
The outcome measure ‘intention to vaccinate’ was also excluded as this does not measure actual 176 
vaccination behaviour and research has shown that not all people that ‘intend to vaccinate’ go on to 177 
get the vaccine [23]. 178 
 179 
2.3 Analysis 180 
 181 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [24] flow 182 
diagram guidance was used to display studies that were identified by the database search and met 183 
inclusion and exclusion criteria (see figure 1). Papers were assessed using the Effective Public Health 184 
Practice Project’s (EPHPP) Quality Assessment Tool for Quantitative studies [25, 26] (appendix 2).  185 
This assessment tool was selected as it allows RCTs and observational studies to be assessed easily 186 
within one tool and has been shown to have excellent inter-rater agreement for the quality grade 187 
awarded to papers within systematic reviews [27]. 188 
 189 
The EPHPP framework [25] assesses the quality of studies against the following criteria: 190 
• Selection bias 191 
• Design 192 
• Confounding 193 
• Blinding 194 
• Data collection 195 
• Withdrawal and opt out of participants 196 
• Intervention integrity  197 
• Analysis 198 
 199 
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Papers were awarded a score of ‘weak’, ‘moderate’ or ‘strong’ based on their design and analysis. 200 
Each paper’s assessment is presented in appendix 2 and the quality score is reported in appendix 1 201 
and 2. 202 
 203 
Where sufficient data was provided in the papers, and the assumptions were met, a risk difference 204 
and a Chi-Squared test for proportions was calculated for each paper (appendix 1). This was done to 205 
allow for a comparison to be made between the effect of the interventions in each paper. The types 206 
of interventions identified in the papers were too heterogeneous to conduct a meta-analysis. The 207 
components of the interventions in these studies were described (appendix 1).  208 
 209 
 210 
3. Results 211 
 212 
3.1 Literature search 213 
 214 
The database search identified 1,062 articles. After duplicates were removed the total number of 215 
articles was 687 (figure 1). Articles were initially screened by title and abstract to assess relevancy 216 
and were also assessed against the inclusion and exclusion criteria. Forty-three articles (including 217 
three articles found through snowballing technique) appeared relevant to the research question and 218 
were assessed against the inclusion and exclusion criteria by full text, at which point a further 21 219 
were excluded. Twenty-two papers were included in this review (figure 1). 220 
 221 
3.2 Main findings 222 
 223 
The majority of the included studies focused on influenza vaccination in pregnancy (18/22) and of 224 
these, 12 were conducted in the USA. The other four studies focusing on influenza vaccination in 225 
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pregnancy occurred in Australia, Canada, Hong Kong and UK. Only four studies looked at strategies 226 
to increase pertussis vaccination and all occurred in the USA. 227 
 228 
Nine studies included in the review were RCTs and the remaining 13 were observational studies 229 
(appendix 1). 230 
 231 
Randomised control trials 232 
 233 
Of the nine RCTs, three were assessed as ‘strong’ [28, 29, 30], three ‘moderate’ [31, 32, 33] and 234 
three ‘weak’ [34, 35, 36] in quality. The weak-quality studies had methodological flaws with 235 
allocation concealment, blinding and power.  236 
 237 
Observational studies 238 
 239 
None of the observational studies presented high quality evidence. Of the 13 papers identified, five 240 
were graded as ‘moderate’ (38.5%) [36-40], and eight as ‘weak’ evidence (61.5%) [35, 41-47 241 
(appendix 2). 242 
 243 
Fifty-four per cent of the observation studies (7/13) assessed the impact of strategies or 244 
interventions that had multiple components so it was difficult to determine which specific elements 245 
of the interventions resulted in an increase of vaccination uptake in pregnant women [35, 38-41, 43, 246 
45]. Elements of each intervention are detailed in appendix 1. 247 
 248 
Also, many of the observational studies were retrospective cohort studies (appendix 1). It was 249 
difficult to ascertain whether changes in vaccination status in observational studies were due to the 250 
intervention, as the control group vaccination rates were taken at a different time period to the 251 
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intervention group. External confounding factors may have influenced the uptake of vaccinations in 252 
the study population, such as greater public awareness of pertussis or influenza. 253 
 254 
Recording vaccination status 255 
 256 
All of the studies used either self-reported vaccination status or electronic health records to record 257 
whether a vaccination had been received during pregnancy. There are problems with both of these 258 
measures for assessing outcome; self-reporting is susceptible to response bias (although perhaps 259 
less so than self-reporting of vaccinations in childhood, since vaccination during pregnancy would 260 
have happened fairly recently), and assessment of electronic records were only able to detect if 261 
vaccination had been received in the facility where the study took place. Only one study [39] 262 
included ‘vaccination received elsewhere’ in electronic medical records. The use of electronic health 263 
records is likely to underestimate vaccine coverage but it is uncertain how self-reported vaccination 264 
status would impact results in the papers. For both of these methods it is likely to have a non-265 
differential impact on the intervention and control groups so this was not recorded as a significant 266 
weakness when grading these papers (appendix 2). 267 
 268 
3.3 Strategies and interventions to increase uptake of pertussis and influenza vaccination in 269 
pregnancy 270 
 271 
We have grouped the effective interventions into three main themes, illustrated in figure 2. We 272 
describe these interventions in more detail below. 273 
 274 
Fifty-five per cent (12/22) of papers found significant improvement (at 95% significance level) in 275 
vaccination coverage following interventions or strategies to increase uptake (appendix 1). 276 
Intervention components in the papers that showed a significant increase in vaccination uptake in 277 
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pregnant women can been seen in table 3. Of these 12 papers, 11 focused on influenza vaccination 278 
in pregnancy and one on pertussis [44].  279 
 280 
The observational studies that were graded as moderate or strong quality [36-40] found a risk 281 
difference of between 9.85 - 36.90 per cent between intervention and control groups for 282 
vaccination. The highest difference between the control and intervention groups were found for 283 
strategies that included education for staff and allowing midwives to provide vaccination with a risk 284 
difference of 36.45 per cent (95% CI: 29.21%, 43.72%; p<0.001) [39], and adding a reminder to 285 
health records about vaccination, risk difference 36.90 per cent (95% CI: 32.10%, 41.40%; p<0.001) 286 
[36]  (appendix 1). 287 
 288 
One RCT found a modest risk difference of 11.12 per cent (95% CI: 2.80%, 19.38%; p<0.01) between 289 
the intervention and control group for a 1-2-1 brief education session for pregnant women including 290 
information on safety, vaccine recommendations and benefits of vaccination [30] (appendix 1). The 291 
other RCT found a risk difference of 39.17 per cent (95% CI: 17.76%, 56.27%; p<0.001) between the 292 
intervention and control group, with the intervention comprising of a patient information pamphlet 293 
with a statement about the importance of vaccination to protect the baby from influenza (appendix 294 
1) [32].  295 
 296 
Midwives vaccinating pregnant women 297 
 298 
In the USA, the majority of vaccination is not provided by midwives. Where healthcare institutions 299 
had implemented a ‘standing order’, allowing midwives to administer pertussis or influenza 300 
vaccination, without seeking permission from a physician or referring to a General Practitioner (GP) 301 
or physician to administer vaccine, vaccination coverage increased [39, 42, 45].  302 
 303 
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Reminders on medical records 304 
 305 
Adding a reminder to medical records (electronic or paper) to prompt antenatal care staff to discuss 306 
and offer vaccination was shown to increase vaccination coverage [33, 37, 38, 44-46].  307 
 308 
Text message reminders 309 
 310 
Three RCTs focusing specifically on text messaging to pregnant women found a lack of significant 311 
effect of text message reminders as method of increasing vaccination in pregnancy [29, 31, , 33].  312 
 313 
Information and education for patients 314 
 315 
Information and education was important for both staff and patients separately. Information for 316 
patients was found to be effective at increasing vaccine coverage when administered through 317 
education sessions, posters or pamphlets [30, 32, 38, 40].  318 
 319 
Three papers [28, 34, 48] used an educational video (providing information on the importance of 320 
vaccination based on theoretic methods of behaviour change) as the intervention to increase 321 
vaccination uptake and found no difference between the control and intervention arms of their 322 
study. However, two of the papers [34, 48] had small sample sizes (n< 35 in each arm of the RCT), 323 
meaning they are unlikely to be sufficiently powered to detect any effect. For one study the 324 
educational video intervention did positively influence vaccination health beliefs but not actual 325 
vaccine behaviour [28]. 326 
 327 
Staff training and education 328 
 329 
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Staff education was important to ensure that staff were equipped with the current information on 330 
vaccination in pregnancy and current guidance on discussing vaccination with pregnant women [38, 331 
40].   332 
 333 
In summary, the intervention components supported by strong or moderate quality studies to 334 
increase vaccination coverage in pregnancy: 335 
 Provision of vaccination by midwives (rather than just physicians or in GP practices) 336 
 Alerts on medical records to prompt staff to discuss vaccination 337 
  Staff education and training 338 
- Information of efficacy, safety, benefits and timing of vaccination 339 
 Education and information for patients  340 
- Information of efficacy, safety, benefits and timing of vaccination 341 
- Distribution of information and education materials within antenatal clinics and 342 
facilities 343 
- Education and information provided by healthcare staff 344 
- Information/referral to places to access vaccination 345 
 346 
 347 
4. Discussion 348 
 349 
4.1 Findings 350 
 351 
The aim of the systematic review was to identify strategies that were effective in increasing uptake 352 
of pertussis and influenza vaccination in pregnant women in high-income countries.  353 
 354 
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The majority of the published articles identified in the review looked at strategies to increase 355 
seasonal influenza vaccination in pregnancy and were conducted in the USA. There were limited 356 
articles that aimed to evaluate strategies to increase pertussis vaccination in pregnancy, which may 357 
be due to recommendations for universal pertussis vaccination being released more recently than 358 
the recommendations around seasonal influenza vaccination in pregnancy. 359 
 360 
Of the articles that found effective strategies to increase vaccination uptake, it was difficult to 361 
identify effectiveness by individual interventions, since many of the studies used multi-component 362 
strategies to address low uptake of vaccination in their study population. However, assessing the 363 
elements of strategies that significantly increased vaccine coverage, in high or moderate quality 364 
papers, we identified that education and information for staff and patients, reminder alerts on 365 
medical records and allowing midwives to also administer vaccination are effective strategies in 366 
increasing vaccination uptake. There is currently no evidence to support the use of text messaging or 367 
educational video-based interventions to increase vaccination uptake in pregnancy in high income 368 
countries. 369 
 370 
4.2 Support for intervention themes identified in the systematic review  371 
There are no other systematic or literature views that solely focus on strategies to increase both 372 
pertussis and influenza vaccination uptake in pregnancy in high-income countries. However, one 373 
systematic review [21], published in 2016, did look at strategies to increase influenza vaccination in 374 
pregnancy and found similar results suggesting the use of vaccination reminders in healthcare 375 
systems and patient information pamphlets can increase vaccine coverage. The authors of this 376 
systematic review [21] also conclude that there is a lack of high quality evidence around 377 
interventions to increase vaccination coverage in pregnancy. It is a public health priority to address 378 
vaccination uptake in pregnancy, given the benefit to infants and pregnant women [21]. 379 
 380 
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While there is limited evidence on strategies to increase vaccination uptake, by looking at previous 381 
research into vaccine hesitancy, it appears the reasons women report for not wanting to receive 382 
vaccination in pregnancy links in with the intervention themes identified in our findings. For 383 
example, two literature reviews [20, 49] have looked at factors that influence vaccine hesitancy in 384 
pregnancy. Both papers found that concerns regarding vaccine safety and efficacy were identified as 385 
barriers to vaccination, as well as not receiving a recommendation from a healthcare professional 386 
and lack of knowledge about vaccination in pregnancy.  387 
 388 
Midwives providing vaccination 389 
Evidence from qualitative interviews suggests that women are left to make their own arrangements 390 
with their GPs for pertussis vaccination during pregnancy and feel vaccination should be provided in 391 
antenatal care [49]. Midwives providing vaccination could improve vaccination uptake [49, 50] and 392 
midwives providing vaccination is currently being trialled in Lewisham and Greenwich National 393 
Health Service (NHS) Trust in London [50]. This supports the findings of this systematic review, that 394 
midwives providing the vaccine themselves could be an effective strategy to increase vaccination 395 
uptake in pregnancy by increasing convenience.  396 
 397 
Staff education and training 398 
Lack of conversation with a healthcare professional about influenza and pertussis vaccination in 399 
pregnancy has been identified as a barrier to vaccination in previous original research into vaccine 400 
hesitancy [51-53]. Survey data has found that 16 - 24 per cent of women had a meaningful 401 
discussion with their GP about pertussis vaccination in pregnancy [54, 55]. Cross-sectional survey 402 
data suggests the principal reason for accepting pertussis vaccination was encouragement or 403 
recommendation from a health professional. A meaningful conversation with a health professional 404 
has been identified as a facilitator to influenza and pertussis vaccination [49, 51, 53-56] with 73 - 96 405 
per cent [51, 55] of women accepting vaccination if a health professional (especially an NHS health 406 
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professional [51]) recommends it. This previous research supports the findings of this paper that 407 
education and training for staff and reminders on health records could increase vaccine uptake. 408 
 409 
Information and education for patients 410 
It has been suggested that women may decline vaccination due to a lack of information and 411 
awareness [54]. Additionally, safety concerns have been identified as a barrier for vaccination in 412 
pregnancy [19, 52, 55] despite extensive research into vaccine safety [2, 10]. Qualitative evidence 413 
from London suggests that many mothers trust the NHS and if the NHS are providing vaccination, 414 
they are more likely to trust the vaccine [51]. It is important to ensure pregnant women are 415 
provided with accurate information about safety, efficacy and the vaccination schedule in 416 
pregnancy, which was identified as an effective strategy in this paper. 417 
 418 
4.3 Limitations 419 
Study limitations include the possibility of selection bias or subjective review. Due to funding 420 
constraints, the papers were screened and assessed by only one researcher. As the papers were 421 
selected from high-income countries, the directness (or generalisability) to England was not 422 
considered a limitation. Although, the majority of papers (n=18) were published in the USA, where a 423 
different healthcare payment system means that individuals (who are not eligible for social support) 424 
are reliant on purchasing insurance to access healthcare and may need to pay for vaccinations if 425 
these are not covered as part of their insurance policy. This may be an additional barrier to 426 
vaccination that is not seen in England due to vaccination being provided for free by the NHS. 427 
 428 
4.4 Recommendations  429 
 430 
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Based on the current evidence and given that vaccination in pregnancy is a public health priority, it 431 
would be advisable that the NHS England and PHE work with Clinical Commissioning Groups and the 432 
providers of antenatal care to put a number of strategies in place: 433 
 434 
1. Implement an alert on health records to prompt healthcare professionals to discuss 435 
vaccination with women during pregnancy. This should be on GP systems as well as 436 
antenatal care systems.  437 
 438 
2. Ensure staff have the knowledge and confidence to discussion vaccination with women 439 
during pregnancy, via staff education and training.  440 
 441 
3. Commissioners of vaccinations and antenatal services should work together to make it 442 
possible for midwives to vaccinate pregnant women during antenatal appointments. This 443 
will remove the additional barrier of mothers needing to make an appointment with their 444 
GP to receive the vaccination.  445 
 446 
4. Provide up-to-date vaccine information leaflets to pregnant women and have posters in GP 447 
surgeries, antenatal clinics, and childcare facilities. 448 
 449 
5. Further research and evaluation of strategies to increase uptake of pertussis and influenza 450 
vaccination in pregnancy.  451 
 452 
 453 
5. Conclusions 454 
 455 
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While there is limited high quality evidence for strategies in high-income countries to increase 456 
coverage of pertussis and influenza vaccination in pregnancy, there are a number of strategies that 457 
have been found to be effective; reminders about vaccination on antenatal healthcare records, 458 
midwives providing vaccination, and education, and information provision for healthcare staff and 459 
patients. We recommend that any futureinterventions to increase influenza and pertussis 460 
vaccination in pregnancy are evaluated to ensure efficacy and to contribute to the evidence base. 461 
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